Glucotrack (GCTK) Long-Term Investments (2015 - 2020)

Glucotrack (GCTK) has 6 years of Long-Term Investments data on file, last reported at $56911.0 in Q2 2020.

• Quarterly Long-Term Investments rose 2.93% year-over-year to $56911.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $56911.0 (up 2.93% YoY) and the FY2019 annual result came in at $57092.0, up 8.53% from the prior year.
• Long-Term Investments improved to $56911.0 in Q2 2020, from $55439.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $57092.0 in Q4 2019 to a low of $35673.0 in Q4 2016.
• A 5-year average of $46277.1 and a median of $43768.5 in 2017 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2018 — Long-Term Investments fell 4.22% — and 2019, when it soared 47.13%.
• Tracing GCTK's Long-Term Investments over 5 years: stood at $35673.0 in 2016, then grew by 10.9% to $39562.0 in 2017, then surged by 32.97% to $52605.0 in 2018, then rose by 8.53% to $57092.0 in 2019, then declined by 0.32% to $56911.0 in 2020.
• The last three Long-Term Investments figures came in at $56911.0 (Q2 2020), $55439.0 (Q1 2020), and $57092.0 (Q4 2019), per Business Quant data.